These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 4444938)
1. [Letter: Treatment of 6 chromomycoses by 5 fluoro-cytosine in French Guyana]. Pradinaud R Nouv Presse Med; 1974 Sep; 3(31):1955. PubMed ID: 4444938 [No Abstract] [Full Text] [Related]
2. [Chromomycosis. Treatment with a combination of thiabendazole and 5-fluorocytosine, 6-year follow-up]. Solano E; Hidalgo H; Castro A; Montero-Gei F Med Cutan Ibero Lat Am; 1983; 11(6):413-8. PubMed ID: 6366398 [TBL] [Abstract][Full Text] [Related]
3. Recent developments in the therapy of chromoblastomycosis. Ferreira Lopes C Bull Pan Am Health Organ; 1981; 15(1):58-64. PubMed ID: 7248640 [No Abstract] [Full Text] [Related]
4. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine. Park SG; Oh SH; Suh SB; Lee KH; Chung KY Br J Dermatol; 2005 Mar; 152(3):560-4. PubMed ID: 15787829 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of chromoblastomycosis with 5-fluorocytosine. Morison WL; Connor B; Clayton Y Br J Dermatol; 1974 Apr; 90(4):445-9. PubMed ID: 4823884 [No Abstract] [Full Text] [Related]
7. In vitro sensitivity to 5-fluorocytosine of strains isolated from patients under treatment for chromomycosis. Gonzaga de Oliveira L; Aparecida de Rezende M; Osorio Cisalpino E; Peixoto de Figueiredo Y; Ferreira Lopes C Int J Dermatol; 1975 Mar; 14(2):141-3. PubMed ID: 1123261 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of chromoblastomycosis with amphotericin B and 5-fluorocytosine]. Astorga E; Bonilla E; MartÃnez C; Mura W Med Cutan Ibero Lat Am; 1981; 9(2):125-8. PubMed ID: 7026925 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of chromoblastomycosis with a new method]. Bopp C Med Cutan Ibero Lat Am; 1976; 4(4):285-92. PubMed ID: 798082 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of chromomycosis with a combination of 5-fluorocytosine and thiabendazole. Apropos of a Zairian case due to Fonsecaea pedrosoi]. De Clercq D; Kakiesse M; De Vroey C; Mazebo P Ann Soc Belg Med Trop; 1985; 65(1):95-7. PubMed ID: 4004379 [No Abstract] [Full Text] [Related]
11. The treatment of chromomycosis with 5-fluorocystine. Chermsirivathana S; Bunyaratavej K; Pupaibul K Int J Dermatol; 1979 Jun; 18(5):377-9. PubMed ID: 468457 [No Abstract] [Full Text] [Related]
12. [Treatment effectiveness of chromomycoses by surgery-thiabendazole in Madagascar (Fort Dauphin)]. Michel P; Le Jeannic P; Andriantsimahavandy A; Mouden JC; Coulanges P Med Trop (Mars); 1999; 59(3):307-8. PubMed ID: 10701214 [No Abstract] [Full Text] [Related]
13. Chromomycosis caused by Philaphora pedrosoi in eastern Nigeria. Gugnani HC; Egere JU; Suseelan AV; Okoro AN; Onuigbo WI J Trop Med Hyg; 1978 Oct; 81(10):208-10. PubMed ID: 731762 [TBL] [Abstract][Full Text] [Related]
14. Chromomycosis due to Cladosporium carrionii treated with 5-fluorocytosine. A case report from northern Nigeria. Jacyk WK Cutis; 1979 May; 23(5):649-50. PubMed ID: 456034 [No Abstract] [Full Text] [Related]
15. [Cerebral chromoblastomycotic abscess treated by surgery and 5-fluorocytosine--a case report (author's transl)]. Moriyama T; Yasunaga A; Ono H; Mori K; Matsumoto K No Shinkei Geka; 1977 Jun; 5(6):685-200. PubMed ID: 917242 [No Abstract] [Full Text] [Related]
16. Flucytosine. An effective oral treatment for chromomycosis. Mauceri AA; Cullen SI; Vandevelde AG; Johnson JE Arch Dermatol; 1974 Jun; 109(6):873-6. PubMed ID: 4830101 [No Abstract] [Full Text] [Related]
17. Therapeutic studies with 5-fluorocytosine in chromoblastomycosis. Lopes CD Int J Dermatol; 1975 May; 14(4):292-3. PubMed ID: 1132932 [No Abstract] [Full Text] [Related]
18. Clinical results with a new antifungal agent. Neu HC Med Times; 1974 Feb; 102(2):75-7 passim. PubMed ID: 4810614 [No Abstract] [Full Text] [Related]
19. Treatment of chromomycosis with a combination of ketoconazole and 5-fluorocytosine. Atukorala DN; Pothupitiya GM Ceylon Med J; 1985 Dec; 30(4):193-5. PubMed ID: 3842101 [No Abstract] [Full Text] [Related]
20. Management of candida peritonitis in a CAPD patient by flucytosine therapy: importance of drug level monitoring in body fluids. Giangrande A; Tortorano AM; Limido A; Viviani MA Boll Ist Sieroter Milan; 1983 Nov; 62(5):478-81. PubMed ID: 6671030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]